+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Myeloid Metaplasia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • PDF Icon

    Report

  • 227 Pages
  • April 2019
  • Region: Global
  • VPA Research
  • ID: 4767871
The global clinical trial report- “2019 Myeloid Metaplasia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Myeloid Metaplasia. It presents in-depth analysis of Myeloid Metaplasia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Myeloid Metaplasia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Myeloid Metaplasia clinical trials by:
  • Current Trial Status

  • Type of the trial

  • Sponsor Type

  • Enrollment Trends

  • Region

  • Countries

  • Trial Phase



The report also identifies the potential drug candidates under development for treatment of Myeloid Metaplasia

The research work is prepared through extensive and continuous research on Myeloid Metaplasia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.

  • Drug candidates currently being researched for administering Myeloid Metaplasia patients are identified

  • The report includes panorama of Myeloid Metaplasia clinical trials across the globe

  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided

  • Companies and universities focusing on Myeloid Metaplasia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)

  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included

  • Both interventional and observational studies are analyzed

  • News and latest developments for the past one year are presented in the report

Table of Contents

1.1 List of Figures1.2 List of Tables
2. Executive Summary
2.1 Myeloid Metaplasia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Myeloid Metaplasia Clinical Trials by Region
2.2.2 Average Enrollment of Myeloid Metaplasia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Myeloid Metaplasia Treatment, 2019
3. Region wise Myeloid Metaplasia Clinical Trials
3.1 Asia Pacific Myeloid Metaplasia Clinical Trials by Country
3.2 Europe Myeloid Metaplasia Clinical Trials by Country
3.3 North America Myeloid Metaplasia Clinical Trials by Country
3.4 Middle East and Africa Myeloid Metaplasia Clinical Trials by Country
3.5 South and Central America Myeloid Metaplasia Clinical Trials by Country
4. Myeloid Metaplasia Clinical Trial Trends
4.1 Start Year wise Myeloid Metaplasia Clinical Trials
4.2 Phase wise Myeloid Metaplasia Clinical Trials
4.3 Trial Status wise Myeloid Metaplasia Clinical Trials
4.4 Trial Type wise Myeloid Metaplasia Clinical Trials
5. Myeloid Metaplasia Average Enrollment Trends
5.1 Average Enrollment in Myeloid Metaplasia Trials by Year
5.2 Average Enrollment in Myeloid Metaplasia Trials by Phase
5.3 Average Enrollment in Myeloid Metaplasia Trials by Status
5.4 Average Enrollment in Myeloid Metaplasia Trials by Type of Trial
6. Companies Participating in Myeloid Metaplasia Clinical Trials
6.1 Myeloid Metaplasia Trials by Sponsor Type
6.2 Myeloid Metaplasia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Myeloid Metaplasia Trials- Phase 1
7.2 Myeloid Metaplasia Trials- Phase 2
7.3 Myeloid Metaplasia Trials- Phase 3
7.4 Myeloid Metaplasia Trials- Phase 4
8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
List of Figures
Figure 1: Myeloid Metaplasia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Myeloid Metaplasia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Myeloid Metaplasia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Myeloid Metaplasia Clinical Trials and Enrolment
Figure 7: North America - Country wise Myeloid Metaplasia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Myeloid Metaplasia Clinical Trials and Enrolment
Figure 9: Myeloid Metaplasia Clinical Trials by Phase
Figure 10: Myeloid Metaplasia Clinical Trials by Trial Status
Figure 11: Myeloid Metaplasia Clinical Trials by Type
Figure 12: Myeloid Metaplasia Clinical Trials by Sponsor Type
Figure 13: Myeloid Metaplasia Clinical Trials by Leading Sponsors
Figure 14: Myeloid Metaplasia Average Enrollment by Phase
Figure 15: Myeloid Metaplasia Average Enrollment by Trial Status
Figure 16: Myeloid Metaplasia Average Enrollment by Type
Figure 17: Myeloid Metaplasia- Average Enrolment by Type of Sponsors
Figure 18: Myeloid Metaplasia- Enrolment by Leading Sponsors
Figure 19: Research Methodology
List of Tables
Table 1: Myeloid Metaplasia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Myeloid Metaplasia Clinical Trials and Enrolment
Table 5: Europe - Country wise Myeloid Metaplasia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Myeloid Metaplasia Clinical Trials and Enrolment
Table 7: North America - Country wise Myeloid Metaplasia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Myeloid Metaplasia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Myeloid Metaplasia Average Enrollment by Phase
Table 15: Myeloid Metaplasia Average Enrollment by Trial Status
Table 16: Myeloid Metaplasia Average Enrollment by Type
Table 17: Myeloid Metaplasia- Average Enrolment by Type of Sponsors
Table 18: Myeloid Metaplasia- Enrolment by Leading Sponsors

Companies Mentioned

  • Aeterna Zentaris Inc

  • Bristol-Myers Squibb Co

  • CASI Pharmaceuticals Inc

  • Celgene Corp

  • Gemin X Pharmaceuticals

  • Merck & Co Inc

  • Novartis AG

  • Prescient Therapeutics Ltd

  • REGiMMUNE Corp

  • Takeda Pharmaceutical Co Ltd